ID   PLB1_YEAST              Reviewed;         664 AA.
AC   P39105; D6VZI2; Q6B2E2;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   07-APR-2021, entry version 156.
DE   RecName: Full=Lysophospholipase 1 {ECO:0000303|PubMed:8051052};
DE            EC=3.1.1.5 {ECO:0000269|PubMed:10497163, ECO:0000269|PubMed:8051052};
DE   AltName: Full=Phospholipase B 1 {ECO:0000305};
DE   Flags: Precursor;
GN   Name=PLB1 {ECO:0000303|PubMed:8051052};
GN   OrderedLocusNames=YMR008C {ECO:0000312|SGD:S000004610};
GN   ORFNames=YM8270.10C {ECO:0000312|SGD:S000004610};
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND CATALYTIC ACTIVITY.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=8051052;
RA   Lee K.S., Patton J.L., Fido M., Hines L.K., Kohlwein S.D., Paltauf F.,
RA   Henry S.A., Levin D.E.;
RT   "The Saccharomyces cerevisiae PLB1 gene encodes a protein required for
RT   lysophospholipase and phospholipase B activity.";
RL   J. Biol. Chem. 269:19725-19730(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169872;
RA   Bowman S., Churcher C.M., Badcock K., Brown D., Chillingworth T.,
RA   Connor R., Dedman K., Devlin K., Gentles S., Hamlin N., Hunt S., Jagels K.,
RA   Lye G., Moule S., Odell C., Pearson D., Rajandream M.A., Rice P.,
RA   Skelton J., Walsh S.V., Whitehead S., Barrell B.G.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XIII.";
RL   Nature 387:90-93(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A., Raphael J.,
RA   Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F., Williamson J.,
RA   Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G., Kolodner R.D.,
RA   LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-encoding
RT   clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
RN   [5]
RP   CATALYTIC ACTIVITY.
RX   PubMed=10231538; DOI=10.1021/bi9824590;
RA   Fyrst H., Oskouian B., Kuypers F.A., Saba J.D.;
RT   "The PLB2 gene of Saccharomyces cerevisiae confers resistance to
RT   lysophosphatidylcholine and encodes a phospholipase B/lysophospholipase.";
RL   Biochemistry 38:5864-5871(1999).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10383953; DOI=10.1128/jb.181.13.3886-3889.1999;
RA   Hamada K., Terashima H., Arisawa M., Yabuki N., Kitada K.;
RT   "Amino acid residues in the omega-minus region participate in cellular
RT   localization of yeast glycosylphosphatidylinositol-attached proteins.";
RL   J. Bacteriol. 181:3886-3889(1999).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=10497163; DOI=10.1074/jbc.274.40.28121;
RA   Merkel O., Fido M., Mayr J.A., Prueger H., Raab F., Zandonella G.,
RA   Kohlwein S.D., Paltauf F.;
RT   "Characterization and function in vivo of two novel phospholipases
RT   B/lysophospholipases from Saccharomyces cerevisiae.";
RL   J. Biol. Chem. 274:28121-28127(1999).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBSTRATE SPECIFICITY.
RX   PubMed=15588231; DOI=10.1042/bj20041272;
RA   Merkel O., Oskolkova O.V., Raab F., El-Toukhy R., Paltauf F.;
RT   "Regulation of activity in vitro and in vivo of three phospholipases B from
RT   Saccharomyces cerevisiae.";
RL   Biochem. J. 387:489-496(2005).
CC   -!- FUNCTION: Sequentially removes both fatty acyl groups from
CC       diacylglycerophospholipids and therefore has both phospholipase B and
CC       lysophospholipase activities. It also displays transacylase activity.
CC       Substrate preference is phosphatidylserine > phosphatidylinositol >>
CC       phosphatidylcholine > phosphatidylethanolamine (PubMed:10497163,
CC       PubMed:8051052). The substrate specificity is pH- and ion-dependent. In
CC       contrast with activities observed at optimum pH 3.5, the order of
CC       substrate preference at pH 5.5 is phosphatidylcholine =
CC       phosphatidylethanolamine >> phosphatidylinositol. Degrades
CC       predominantly phosphatidylcholine and to some extent
CC       phosphatidylinositol in vivo (PubMed:15588231).
CC       {ECO:0000269|PubMed:10497163, ECO:0000269|PubMed:15588231,
CC       ECO:0000269|PubMed:8051052}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphocholine + H2O = a fatty acid +
CC         H(+) + sn-glycerol 3-phosphocholine; Xref=Rhea:RHEA:15177,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:16870,
CC         ChEBI:CHEBI:28868, ChEBI:CHEBI:58168; EC=3.1.1.5;
CC         Evidence={ECO:0000269|PubMed:10497163, ECO:0000269|PubMed:8051052};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phospho-(1D-myo-inositol) + H2O = a
CC         carboxylate + H(+) + sn-glycero-3-phospho-1D-myo-inositol;
CC         Xref=Rhea:RHEA:32987, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29067, ChEBI:CHEBI:58444, ChEBI:CHEBI:64771;
CC         Evidence={ECO:0000269|PubMed:10497163};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32988;
CC         Evidence={ECO:0000305|PubMed:10497163};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phospho-L-serine + H2O = a fatty acid +
CC         H(+) + sn-glycero-3-phospho-L-serine; Xref=Rhea:RHEA:32979,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28868,
CC         ChEBI:CHEBI:64379, ChEBI:CHEBI:64765;
CC         Evidence={ECO:0000269|PubMed:10497163};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32980;
CC         Evidence={ECO:0000305|PubMed:10497163};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) + 2 H2O =
CC         2 a carboxylate + 2 H(+) + sn-glycero-3-phospho-1D-myo-inositol;
CC         Xref=Rhea:RHEA:32983, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29067, ChEBI:CHEBI:57880, ChEBI:CHEBI:58444;
CC         Evidence={ECO:0000269|PubMed:10497163, ECO:0000269|PubMed:15588231};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32984;
CC         Evidence={ECO:0000305|PubMed:10497163, ECO:0000305|PubMed:15588231};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-L-serine + 2 H2O = 2 a
CC         carboxylate + 2 H(+) + sn-glycero-3-phospho-L-serine;
CC         Xref=Rhea:RHEA:32975, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29067, ChEBI:CHEBI:57262, ChEBI:CHEBI:64765;
CC         Evidence={ECO:0000269|PubMed:10497163, ECO:0000269|PubMed:15588231};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32976;
CC         Evidence={ECO:0000305|PubMed:10497163, ECO:0000305|PubMed:15588231};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 1-hexadecanoyl-sn-glycero-3-phosphocholine = 1,2-
CC         dihexadecanoyl-sn-glycero-3-phosphocholine + sn-glycerol 3-
CC         phosphocholine; Xref=Rhea:RHEA:40879, ChEBI:CHEBI:16870,
CC         ChEBI:CHEBI:72998, ChEBI:CHEBI:72999;
CC         Evidence={ECO:0000269|PubMed:8051052};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40880;
CC         Evidence={ECO:0000305|PubMed:8051052};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phosphocholine + H2O = H(+) +
CC         hexadecanoate + sn-glycerol 3-phosphocholine; Xref=Rhea:RHEA:40435,
CC         ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16870, ChEBI:CHEBI:72998;
CC         Evidence={ECO:0000269|PubMed:10231538, ECO:0000269|PubMed:8051052};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40436;
CC         Evidence={ECO:0000305|PubMed:10231538, ECO:0000305|PubMed:8051052};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihexadecanoyl-sn-glycero-3-phosphocholine + H2O = 1-
CC         hexadecanoyl-sn-glycero-3-phosphocholine + H(+) + hexadecanoate;
CC         Xref=Rhea:RHEA:41223, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:72998, ChEBI:CHEBI:72999;
CC         Evidence={ECO:0000269|PubMed:10231538, ECO:0000269|PubMed:8051052};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41224;
CC         Evidence={ECO:0000305|PubMed:10231538, ECO:0000305|PubMed:8051052};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305|PubMed:10383953,
CC       ECO:0000305|PubMed:10497163}; Lipid-anchor, GPI-anchor
CC       {ECO:0000305|PubMed:10383953, ECO:0000305|PubMed:10497163}.
CC   -!- SIMILARITY: Belongs to the lysophospholipase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L23089; AAA61611.1; -; Genomic_DNA.
DR   EMBL; Z48613; CAA88523.1; -; Genomic_DNA.
DR   EMBL; AY692788; AAT92807.1; -; Genomic_DNA.
DR   EMBL; BK006946; DAA09906.1; -; Genomic_DNA.
DR   PIR; S53037; S53037.
DR   RefSeq; NP_013721.1; NM_001182504.1.
DR   BioGRID; 35177; 46.
DR   DIP; DIP-2804N; -.
DR   IntAct; P39105; 2.
DR   MINT; P39105; -.
DR   STRING; 4932.YMR008C; -.
DR   SwissLipids; SLP:000000078; -.
DR   MaxQB; P39105; -.
DR   PaxDb; P39105; -.
DR   PRIDE; P39105; -.
DR   EnsemblFungi; YMR008C_mRNA; YMR008C; YMR008C.
DR   GeneID; 855020; -.
DR   KEGG; sce:YMR008C; -.
DR   SGD; S000004610; PLB1.
DR   VEuPathDB; FungiDB:YMR008C; -.
DR   eggNOG; KOG1325; Eukaryota.
DR   GeneTree; ENSGT01000000214502; -.
DR   HOGENOM; CLU_014602_0_0_1; -.
DR   InParanoid; P39105; -.
DR   OMA; TANIHNW; -.
DR   BioCyc; MetaCyc:YMR008C-MONOMER; -.
DR   Reactome; R-SCE-111995; phospho-PLA2 pathway.
DR   Reactome; R-SCE-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-SCE-1482798; Acyl chain remodeling of CL.
DR   Reactome; R-SCE-1482801; Acyl chain remodelling of PS.
DR   Reactome; R-SCE-1482839; Acyl chain remodelling of PE.
DR   Reactome; R-SCE-1482922; Acyl chain remodelling of PI.
DR   Reactome; R-SCE-1482925; Acyl chain remodelling of PG.
DR   Reactome; R-SCE-1483115; Hydrolysis of LPC.
DR   Reactome; R-SCE-1483152; Hydrolysis of LPE.
DR   Reactome; R-SCE-1483166; Synthesis of PA.
DR   Reactome; R-SCE-2142753; Arachidonic acid metabolism.
DR   Reactome; R-SCE-418592; ADP signalling through P2Y purinoceptor 1.
DR   Reactome; R-SCE-432142; Platelet sensitization by LDL.
DR   Reactome; R-SCE-6811436; COPI-independent Golgi-to-ER retrograde traffic.
DR   PRO; PR:P39105; -.
DR   Proteomes; UP000002311; Chromosome XIII.
DR   RNAct; P39105; protein.
DR   GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0071944; C:cell periphery; HDA:SGD.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:SGD.
DR   GO; GO:0005576; C:extracellular region; IBA:GO_Central.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0042597; C:periplasmic space; IDA:SGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:SGD.
DR   GO; GO:0004622; F:lysophospholipase activity; IMP:SGD.
DR   GO; GO:0102545; F:phosphatidyl phospholipase B activity; IEA:UniProtKB-EC.
DR   GO; GO:0004623; F:phospholipase A2 activity; IBA:GO_Central.
DR   GO; GO:0046475; P:glycerophospholipid catabolic process; IBA:GO_Central.
DR   GO; GO:0006650; P:glycerophospholipid metabolic process; IMP:SGD.
DR   GO; GO:0036151; P:phosphatidylcholine acyl-chain remodeling; IMP:SGD.
DR   InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR   InterPro; IPR002642; LysoPLipase_cat_dom.
DR   Pfam; PF01735; PLA2_B; 1.
DR   SMART; SM00022; PLAc; 1.
DR   SUPFAM; SSF52151; SSF52151; 1.
DR   PROSITE; PS51210; PLA2C; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Glycoprotein; GPI-anchor; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Lipoprotein; Membrane; Reference proteome; Signal.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..634
FT                   /note="Lysophospholipase 1"
FT                   /id="PRO_0000024646"
FT   PROPEP          635..664
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000372442"
FT   DOMAIN          35..586
FT                   /note="PLA2c"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00555"
FT   COMPBIAS        587..629
FT                   /note="Ala/Ser-rich"
FT   LIPID           634
FT                   /note="GPI-anchor amidated asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        26
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        33
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        52
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        78
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        92
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        123
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        160
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        170
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        215
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        277
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        307
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        345
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        388
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        459
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        489
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        513
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        541
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        565
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        582
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        32
FT                   /note="A -> S (in Ref. 1; AAA61611)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        93
FT                   /note="S -> P (in Ref. 4; AAT92807)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        494
FT                   /note="E -> D (in Ref. 1; AAA61611)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   664 AA;  71667 MW;  E05A585E7AB73F34 CRC64;
     MKLQSLLVSA AVLTSLTENV NAWSPNNSYV PANVTCDDDI NLVREASGLS DNETEWLKKR
     DAYTKEALHS FLNRATSNFS DTSLLSTLFG SNSSNMPKIA VACSGGGYRA MLSGAGMLAA
     MDNRTDGANE HGLGGLLQGA TYLAGLSGGN WLTSTLAWNN WTSVQAIVDN TTESNSIWDI
     SHSILTPDGI NIFKTGSRWD DISDDVQDKK DAGFNISLAD VWGRALAYNF WPSLHRGGVG
     YTWSTLREAD VFKNGEMPFP ITVADGRYPG TTVINLNATL FEFNPFEMGS WDPTLNAFTD
     VKYLGTNVTN GKPVNKGQCI AGFDNTGFIT ATSSTLFNQF LLRLNSTDLP SFIANLATDF
     LEDLSDNSDD IAIYAPNPFK EANFLQKNAT SSIIESEYLF LVDGGEDNQN IPLVPLLQKE
     RELDVIFALD NSADTDDYWP DGASLVNTYQ RQFGSQGLNL SFPYVPDVNT FVNLGLNKKP
     TFFGCDARNL TDLEYIPPLI VYIPNSRHSF NGNQSTFKMS YSDSERLGMI KNGFEAATMG
     NFTDDSDFLG CVGCAIIRRK QQNLNATLPS ECSQCFTNYC WNGTIDSRSV SGVGNDDYSS
     SASLSASAAA ASASASASAS ASASASGSST HKKNAGNALV NYSNLNTNTF IGVLSVISAV
     FGLI
//
